v3.26.1
Business Combinations - Summary of the Purchase Price (Details) - USD ($)
$ in Thousands
6 Months Ended
Mar. 04, 2026
Mar. 31, 2026
Mar. 31, 2025
Business Combination [Line Items]      
Contingent consideration   $ 2,483  
Cash paid, net of cash acquired   $ 11,017 $ 0
UK Biocentre      
Business Combination [Line Items]      
Cash paid at closing $ 14,455    
Transaction bonus paid on March 27, 2026 1,329    
Preexisting contractual liability settlement 13,841    
Transaction expenses 133    
Contingent consideration 2,483    
Business combination, total consideration transferred, gross 32,241    
UK Biocentre cash balance at closing 4,767    
Purchase price, net of cash acquired 27,474    
Cash paid, net of cash acquired $ 11,017